Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
2021 · Neuromuscular Disorders · 164 citations
https://doi.org/10.1016/j.nmd.2021.03.007
D
David Jacquier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
374
Citations
8
h-index
8
i10-index
David Jacquier is an academic researcher from University of Lausanne. The author has contributed to research in topics: Neurogenetic and Muscular Disorders Research & Family and Disability Support Research & Congenital Anomalies and Fetal Surgery. The author has an h-index of 8, co-authored 23 publications.
ORCID: 0000-0002-6173-2905Papers by this author
worksTreatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study
2023 · BMC Neurology · 40 citations
https://doi.org/10.1186/s12883-023-03133-6
Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy
2025 · Clinical Neurology and Neurosurgery · 4 citations
https://doi.org/10.1016/j.clineuro.2025.108983
[Understand, assess and manage the pain of children with profound intellectual and multiple disabilities].
2022 · PubMed · 0 citations
https://doi.org/10.53738/revmed.2022.18.770.310
516PNewborn screening for spinal muscular atrophy: first anniversary in Switzerland
2025 · Neuromuscular Disorders · 0 citations
https://doi.org/10.1016/j.nmd.2025.105605
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat